Active Ingredient History
Cefuroxime is a semisynthetic, broad-spectrum, cephalosporin antibiotic. Cefuroxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefuroxime has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria. Cefuroxime has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infection: Enterobacter spp., Escherichia coli, Klebsiella spp., Haemophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes. Cefuroxime is indicated for the treatment of patients with septicemia, meningitis, gonorrhea, lower respiratory tract, urinary tract, skin and skin-structure, bone and joint infections caused by susceptible strains of the designated organisms. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Bacterial Infections (approved 1983)
Antibiotic Prophylaxis (Phase 2)
Appendicitis (Phase 4)
Bacteremia (Phase 4)
Bacterial Infections (Phase 4)
Cesarean Section (Phase 4)
Colorectal Surgery (Phase 2)
Community-Acquired Infections (Phase 4)
Duodenal Ulcer (Phase 3)
Enterobacteriaceae Infections (Phase 3)
Erythema (Phase 4)
General Surgery (Phase 4)
Healthy Volunteers (Phase 1)
HIV Infections (Phase 2)
Infant, Premature (Phase 4)
Infections ()
Intestinal Diseases (Phase 3)
Medicine, Chinese Traditional (Early Phase 1)
Obesity (Phase 4)
Osteoarthritis, Knee (Phase 4)
Pancreatic Neoplasms (Phase 4)
Pneumonia (Phase 3)
Postoperative Complications (Phase 4)
Respiratory Tract Infections (Early Phase 1)
Signs and Symptoms (Phase 4)
Sinusitis (Phase 2)
Streptococcal Infections (Phase 4)
Surgical Wound Infection (Phase 4)
Urinary Bladder Neoplasms (Phase 3)
Urinary Tract Infections (Phase 4)
Wound Infection (Phase 4)
Wounds and Injuries (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
